The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
CYP2C19 and CYP2D6 genotypes in Pacific peoples
Open accessAbstract
The study of pharmacogenetic variants in populations which reside in Oceania has been focused mainly on CYP2C19 and CYP2D6. Statements about the high prevalence of CYP2C19 no function genotype in ‘Pacific Islanders’ can be found in the literature. This review article summarizes the published information about these pharmacogenes in this geographical region and highlights the differences observed between Melanesian and Polynesian populations. It is not appropriate to combine the prevalence data of pharmacogenetic variants, particularly CYP2C19, across this region. Indeed, apocryphal assumptions about CYP2C19 no function alleles and possible effect on the therapeutic activity of clopidogrel are unhelpful and reiterate the importance of assessing the individual patient rather than relying on inappropriate ethnicity‐based assumptions for drug dosing decisions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, studies found that clopidogrel was less effective in Pacific Islanders [26]”
From Hasty generalizations and generics in medical research: A systematic review (2024) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Demographic History of Oceania Inferred from Genome-wide Data
Wollstein, A., Lao, O., Becker, C., Brauer, S., Trent, R. J., Nürnberg, P., Stoneking, M., & Kayser, M. (2010) · Current Biology · doi:10.1016/j.cub.2010.10.040 · Cited by 218
Zabalza, M., Subirana, I., Sala, J., Lluís-Ganella, C., Lucas, G., Tomás, M., Masià, R., Marrugat, J., Brugada, R., & Elosúa, R. (2011) · Heart · doi:10.1136/hrt.2011.227652 · Cited by 177
Fricke-Galindo, I., Céspedes-Garro, C., Rodrigues‐Soares, F., Naranjo, M. E. G., Delgado, A., de Andrés, F., López, M., Peñas‐Lledó, E., & LLerena, A. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.70 · Cited by 174
The impact of whole-genome sequencing on the reconstruction of human population history
Veeramah, K. R., & Hammer, M. F. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3625 · Cited by 151
LLerena, A., Naranjo, M. E. G., Rodrigues‐Soares, F., Peñas‐Lledó, E., Fariñas, H., & Tarazona‐Santos, E. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.964204 · Cited by 149
Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea
Mehlotra, R. K., Ziats, M. N., Bockarie, M. J., & Zimmerman, P. A. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0092-9 · Cited by 94
Precision medicine: does ethnicity information complement genotype-based prescribing decisions?
Shah, R. R., & Gaedigk, A. (2017) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098617743393 · Cited by 80
Griese, E., Ilett, K. F., Kitteringham, N. R., Eichelbaum, M. F., Powell, H., Spargo, R. M., Souëf, P. N. L., Musk, A. W., & Minchin, R. F. (2001) · Pharmacogenetics · doi:10.1097/00008571-200102000-00008 · Cited by 71
The Hawaii Clopidogrel Lawsuit: The Possible Effect on Clinical Laboratory Testing
Wu, A. H. B., White, M. J., Oh, S., & Burchard, E. G. (2015) · Personalized Medicine · doi:10.2217/pme.15.4 · Cited by 68
Kancko, A., Bergqvist, Y., Taleo, G. K., Kobayakawa, T., Ishizaki, T., & rkman, A. B. (1999) · Pharmacogenetics · doi:10.1097/00008571-199906000-00006 · Cited by 64
Cited by
Sorted by citations
Zhou, Y., & Lauschke, V. M. (2021) · Human Genetics · doi:10.1007/s00439-021-02385-x · Cited by 91
Precision medicine: does ethnicity information complement genotype-based prescribing decisions?
Shah, R. R., & Gaedigk, A. (2017) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098617743393 · Cited by 80
From genes to drugs: CYP2C19 and pharmacogenetics in clinical practice
Shubbar, Q., Alchakee, A., Issa, K. W., Adi, A. J., Shorbagi, A., & Saber-Ayad, M. M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1326776 · Cited by 51
Somogyi, A. A., Barratt, D. T., Phillips, E. J., Moore, K., Ilyas, F., & Gabb, G. M. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14025 · Cited by 23
Rico, E. M. G., Kikuchi, A., Saito, T., Kumondai, M., Hishinuma, E., Kaneko, A., Chan, C. W., Gitaka, J., Nakayoshi, T., Oda, A., et al. (2019) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2019.07.003 · Cited by 14
Metadata
- Authors
- Helsby, N. A.
- Affiliations
- University of Auckland (NZ)
- Corresponding author
- Helsby, Nuala A.
- ORCID
- Helsby, Nuala A.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2016-08-26
- Volume
- 82
- Issue
- 5
- Pages
- 1303-1307
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- PMC
- PMC5061802
- OpenAlex
- W2432817469
- Cited by
- 20
- References
- 27
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 2
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Clinical Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ResearchSpace (University of Auckland) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- CYP2C19, CYP2D6, pharmacogenetic variants, Pacific Islanders, Melanesian population, Polynesian populations, CYP2C19 loss-of-function alleles, clopidogrel response, ethnic differences in drug response, individualized dosing, Oceania
- MeSH terms
- Pharmacogenomic Variants, Pacific Island People, Genotype, Humans, Melanesia, Polynesia, Cytochrome P-450 CYP2D6, Cytochrome P-450 CYP2C19
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CYP2C19 and CYP2D6 genotypes in Pacific peoples. https://app.cochat.ai/papers/10.1111/bcp.13045
- The paper
- Helsby, N. A. (2016). CYP2C19 and CYP2D6 genotypes in Pacific peoples. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.13045
